Dyslipidemia

Study results show testosterone therapy reduces total cholesterol, low-density lipoprotein cholesterol, and triglycerides while boosting high-density lipoprotein cholesterol.

Several studies have shown good results with Roux-en-Y gastric bypass and laparoscopic gastric banding when combined with lifestyle modifications in severely overweight patients with type 2 diabetes.

Study results presented at ACC.14 show treatment with PCSK9 inhibitor evolocumab significantly reduces LDL-cholesterol levels in patients with hypercholesterolemia.

Thomas Dayspring, MD, FACP, FNLA, NCMP, discusses the promises and pitfalls of the 2013 American College of Cardiology/American Heart Association Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

Researchers estimate 43% of the roughly 3.1 million kidney stone episodes among US diabetics are related to type 2 diabetes mellitus (T2DM), while another 680,000 cases may result from poor glycemic control.

A researcher from the University of Central Florida Medical School addresses many concerns and misperceptions of fructose-containing sugars.

The risk calculator tool and recommendations included in the new American College of Cardiology (ACC)/American Heart Association (AHA) hyperlipidemia guidelines are open to significant debate.

A study published in the Journal of Urology found morbidly obese patients are more likely to develop uric acid kidney stones and less likely to develop calcium oxalate stones compared to normal weight controls.

Study results show improvements in body composition, intrahepatic lipids, and cardiovascular risk markers in obese men treated with growth hormone for six months compared with placebo.

As an adjunct to diet and exercise, Amarin's lipid-regulating agent Vascepa (icosapent ethyl capsules) is indicated to reduce triglyceride levels in adult patients with severe hypertriglyceridemia, or very high triglyceride (TG) levels greater than or equal to 500 milligrams per deciliter (mg/dL).

Results from the RELAX-AHF show serelaxin reduces cardiovascular deaths and improves symptoms in patients with heart failure.

Results from a sub-study of the Trial to Assess Chelation Therapy (TACT) that focused on quality of life issues in patients who had previously suffered a heart attack and were treated with chelation therapy reveal no improvements in these patients' quality of life.

Autophagy may provide an entirely new target to reverse atherosclerosis.

Podcast discussion of the value of CT angiography to measure stenosis severity and predict ischemia.

Video explores current options for managing hypertension and atherosclerosis.

The American Heart Association recently revealed its annual list of the most important cardiovascular and stroke research findings from the past year.

The goal when evaluating patients for CVD risk is to know what signs to look for and to devise an evidence-based, individualized treatment plan.

With Barbara Walters' announcement that she is scheduled to undergo surgery to replace a faulty aortic valve (most likely caused by stenosis of the aortic valve, according to Sara Sirna, MD, of the Temple Heart Center), your patients may be asking you questions about stenosis, aortic valve replacement surgery, mitral valve regurgitation, and a other related topics.

Well, I really do know why I bother with all of the hassle and red tape that is the hallmark of modern medicine – I do it for my patients.

I thought I lost a patient a few weeks ago. No, he didn't die, but after his office visit, I had the distinct impression that he might not come back. My job is to take care of my patients' health. But sometimes I'm just the messenger.

This CME activity examines the science of atherosclerotic disease development and discusses the cost-effective benefits of primary and secondary prevention of atherosclerotic disease.

As the mean BMI in the U.S. edges higher, I thought that a discussion of 2 recent analyses regarding lipids was pertinent to the season.

I am convinced that we essentially sabotage both our guests and ourselves when we offer only these high calorie and often totally unhealthy options time and time again.

Circulating biomarkers have been used in cardiovascular medicine as predictors of incident or prevalent disease.

We assessed the association between the incidence of coronary heart disease and alcohol consumption among hypertensive men enrolled in the Health "Professionals" Follow-Up Study. Moderate alcohol consumption (1 to 2 drinks per day) was associated with a lower risk of myocardial infarction, as in the general population, but was not associated with the risks of stroke, total mortality, or mortality from cardiovascular causes. These results show that men with hypertension who drink moderately may not need to change their drinking habits.